New drug therapies
Olié, J.P.; Baylé, F.J.
L'Encephale 22(Special Issue 3): 63-71; Discussion 76
1996
ISSN/ISBN: 0013-7006 PMID: 8954280 Document Number: 455862
Document emailed within 1 workday
Related Documents
Kumar, S.; Rao, P.S.S.; Earla, R.; Kumar, A. 2015: Drug-drug interactions between anti-retroviral therapies and drugs of abuse in HIV systems Expert Opinion on Drug Metabolism and Toxicology 11(3): 343-355Pillay, D.; Albert, J.; Bertagnolio, S.; Boucher, C.; Brun-Vezinet, F.; Clotet, B.; Giaquinto, C.; Perno, C.F. 2013: Implications of HIV drug resistance on first- and second-line therapies in resource-limited settings: report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network Antiviral Therapy 18(6): 831-836
Farlow, M.R. 2005: Combination drug therapies for AD: progress is slow, but we must keep trying Geriatrics 60(6): 13-14
Amidon, T.M. 1995: Mi survivors: using drug therapies to protect the heart Geriatrics 50(10): 26-28; 31-34, 36
Katzenstein, D. 1997: Combination therapies for HIV infection and genomic drug resistance Lancet 350(9083): 970-971
Henry, B.W.; Overall, J.E.; Markette, J.R. 1971: Comparison of major drug therapies for alleviation of anxiety and depression Diseases of the Nervous System 32(10): 655-667
McCracken, J.T. 2005: Safety issues with drug therapies for autism spectrum disorders Journal of Clinical Psychiatry 66(Suppl 10): 32-37
Listello, D.; Glauser, F. 1992: COPD: primary care management with drug and oxygen therapies Geriatrics 47(12): 28-30; 35-38
Listello, D.; Glauser, F. 1992: COPD: primary care management with drug and oxygen therapies Geriatrics 47(12): 28-30; 35-38
Tunuguntla, A. 2007: Emerging drug therapies for the management of acute decompensated heart failure Tennessee Medicine: Journal of the Tennessee Medical Association 100(11): 33-37
Cohen, J. 1996: AIDS conference. Chemokines share center stage with drug therapies Science 273(5273): 302-303
Verrando, R.; Robaeys, G.; Matheï, C.; Buntinx, F. 2005: Methadone and buprenorphine maintenance therapies for patients with hepatitis C virus infected after intravenous drug use Acta Gastro-Enterologica Belgica 68(1): 81-85
Komiya, R.; Kamintani, K.; Kubo, E.; Hattori, M.; Kataoka, H.; Iwase, Y.; Miyoshi, H.; Minami, M.; Kato, S.; Arai, R.; Yoshida, H. 2014: Perioperative management and postoperative complication rates of patients on dual antiplatelet therapies after coronary drug eluting stent implantation Masui. Japanese Journal of Anesthesiology 63(6): 629-635
Gotoh, M. 2009: Treatment and rehabilitation programs for young alcoholics: acquiring the ability through group therapies and cognitive-behavioral therapies to communicate with others to lead a new life Nihon Arukoru Yakubutsu Igakkai Zasshi 44(5): 579-603
Allen, J.P.; Litten, R.Z.; Fertig, J.B. 1995: NIDA-NIAAA workshop: efficacy of therapies in drug and alcohol addiction. Strategies for treatment of alcohol problems Psychopharmacology Bulletin 31(4): 665-669
Campbell, R.K.; Cobble, M.E.; Reid, T.S.; Shomali, M.E. 2010: Distinguishing among incretin-based therapies. Safety, tolerability, and nonglycemic effects of incretin-based therapies Journal of Family Practice 59(9 Suppl 1: S20-S27
Andersson, M.L.; Böttiger, Y.; Lindh, J.D.; Wettermark, B.; Eiermann, B. 2013: Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care European Journal of Clinical Pharmacology 69(3): 565-571
Nishikaze, O. 1975: Drug-drug interaction and drug-induced interference with clinical laboratory test procedures--chairman's introductory remarks Rinsho Byori. Japanese Journal of Clinical Pathology 23(2): 75
Matsuda, T. 1993: Antithrombotic drug (thrombolytic drug, anticoagulant, antiplatelet drug) Nihon Rinsho. Japanese Journal of Clinical Medicine 51 Suppl: 179-185
Kohl, C.; Steinkellner, M. 2000: Prediction of pharmacokinetic drug/drug interactions from in vitro data: interactions of the nonsteroidal anti-inflammatory drug lornoxicam with oral anticoagulants Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(2): 161-168